Secure Maximum Valuation by Becoming the Buyer’s First Choice
Most mid-market health tech and pharmacy CEOs enter an exit process underprepared, and it costs them.
The hard truth is:
Valuation isn’t just about numbers. It’s about confidence.
Buyers will pay more when they believe you’re the category-defining company they can’t afford to miss.
But when your company shows up as the obvious premium acquisition, everything changes: buyers compete, valuations climb, and you control the deal.
That’s exactly what our Premium Acquisition Sprint™ delivers: a focused 90-day engagement that reshapes how buyers, investors, and partners see your business so you can command attention, spark competition, and exit on your terms.
Walk Into Buyer Talks With Proof, Clarity, and a Premium Narrative
Selling a company should be a powerful position, but many founders walk into acquisition talks reactive, unprepared, and undervalued. Legacy DNA built the Premium Acquisition Sprint™ to give CEOs a low-risk, high-impact way to prepare fast.
After 90 days, you’ll have:
A premium acquisition narrative that positions you as a market leader.
Proof that supports your valuation and facilitates due diligence.
Clarity on your top buyer targets and how to create competitive tension.
A leadership team aligned on a single, valuation-focused growth story.
Executive credibility and visibility to attract investor and buyer interest early.
Instead of hoping buyers “see” your value, you’ll show them clearly, credibly, and competitively.
This isn’t a theory deck. It’s a fast, focused transformation that builds buyer confidence and competition without disrupting your operations.
Here's what our customers have to say:
“Our organization’s growth has looked like a hockey stick, and a lot of that credit goes to Dr. Roxy and her team at Legacy DNA. Their innovative thinking and deep understanding of healthcare helped us create a direct-to-consumer model that flourished and ultimately led to our acquisition by one of the largest healthcare plans in the U.S.” - Legacy DNA customer.
A Strategic Repositioning: Our Proven 4-Phase Sprint
Our Premium Acquisition Sprint is not a gentle refresh; it’s a comprehensive brand and narrative transformation designed to increase buyer confidence and valuation rapidly.
Phase 1: Diagnostic + Kickoff (Week 1)
We uncover the risks that drain valuation and align leadership on the exit vision.
Exit Readiness Assessment: A deep audit of positioning, data, traction, and market perception.
Leadership Alignment Workshop: Unite executives around exit goals, surface gaps, and set the strategic direction.
Phase 2: Position for Premium Valuation (Weeks 2–4)
We craft a story that proves category leadership and demonstrates why you’re worth more to buyers.
Exit Narrative Blueprint™: An interactive process to build a compelling growth + impact story.
Differentiation Playbook™: Clear, bold category positioning with messaging and proof competitors can’t touch.
Phase 3: Prove Market Value (Weeks 5–8)
We gather and package hard market evidence that makes your valuation undeniable.
Market Proof Pack™:Traction data, outcomes, and case studies, packaged for buyer diligence.
Acquisition Readiness KPIs: Growth, retention, expansion, and other key signals linked directly to valuation.
Validation Pulse Check: “Mock buyer” feedback from trusted advisors or investors to strengthen your positioning.
Phase 4: Elevate Buyer Demand (Weeks 9–12)
We equip you to spark competitive interest and sustain momentum after the sprint
Buyer Targeting Insights™: Map top acquirers and understand their buying triggers.
Executive Visibility Toolkit: CEO assets, PR hooks, and credibility playbook to stay top-of-mind.
Exit Roadmap: Step-by-step action plan to maintain buyer engagement and keep your valuation story strong.
Turn uncertainty into leverage. Book your Premium Acquisition Sprint today and walk into acquisition talks with a clear, defensible, and premium-worthy narrative.
Legacy DNA Builds Buyer-Ready Brands That Command Premium Deals
You could work with a generic agency. You could hire consultants with no healthtech expertise. But here’s what makes Legacy DNA different and why our clients win bigger exits:
Deep Health Innovation Expertise
We live and breathe health tech, med tech, women’s health, digital therapeutics, and specialty pharmacy.
As a growth agency, we’ve helped dozens of companies in your space sharpen their narratives for scaling and exits.
Helped a pharmacy grow 968% from millions to billions by reframing its category position.
Guided a healthtech platform from $50M to $500M by sharpening its brand and exit narrative.
Turned a stalled go-to-market strategy into a “strategic powerhouse” that buyers competed to acquire.
These are not surface-level wins; they’re valuation-changing transformations.
Exit-Centered From Day One
Every recommendation is made with an acquirer’s lens: risk reduction, proof of traction, and market leadership.
Hands-On Strategy + Execution Coaching
We don’t hand over slides and walk away. We guide alignment, facilitate decisions, and coach your team to ensure the plan is executed effectively.
Unmatched Authority
Dr. Roxie Mooney, the only person with a doctorate in commercializing healthcare technology, has launched 100+ innovations and played key roles in multiple successful exits.
With Legacy DNA, you gain a strategist who’s been inside real deals and knows what buyers look for.
Frequently Asked Questions
-
We work with mid-market healthtech and pharmacy CEOs/founders, often PE-backed, who are 12–36 months away from a potential acquisition or capital event and want to secure a stronger valuation.
-
The Exit Readiness Sprint™ strengthens customer-facing fundamentals, enabling you to scale with confidence.
The Premium Acquisition Sprint™ goes further, crafting a premium exit narrative, packaging proof buyers demand, and mapping top acquirers to spark competitive tension.
-
You’ll walk away with a buyer-ready growth story, clear differentiation, hard market proof, and insights on who’s likely to acquire you, all packaged to accelerate buyer interest and valuation.
-
No. We partner with your existing team. We provide the strategic clarity, frameworks, and buyer-focused assets they need to execute at a higher level.
-
We uncover valuation-draining gaps, build a narrative that signals category leadership, and package proof that makes your business look low-risk and high-growth, exactly what buyers pay more for.
-
Expect a few focused workshops and key review sessions across the 12 weeks. We lead the process so you stay focused on running the business while still shaping the exit story.
-
No, it’s most powerful before you engage buyers. Our process helps you control the narrative, create competitive tension, and enter discussions positioned as the premium acquisition target.
-
Yes. The same assets and proof that fuel buyer confidence also strengthen your fundraising narrative and appeal to strategic investors.
-
That’s okay. We help you clarify your strongest proof points, position your growth story credibly, and identify where to focus before buyers begin their due diligence.
-
Most CEOs begin with this 90-day Sprint because it’s low-risk, highly focused, and delivers enterprise-ready assets fast. From there, many expand into ongoing commercialization support to keep building valuation momentum.
Ready to Become the Premium Acquisition Buyers Compete For?
A few months of preparation can mean the difference between a good deal and a game-changing exit.
Don’t enter the market hoping buyers see your value. Show them. Shape their perception. Drive up demand.
This small, independent specialty pharmacy wanted to dance with the giants, but first, they needed to find their rhythm. Armed with stronger branding, positioning, and thought leadership, they learned new routines. It wasn’t long before they could jump on the dance floor and hustle their way to explosive growth (968% in one decade), taking their pharmacy from millions to billions.
Embracing a paradigm shift from traditional marketing, this tech platform undertook a comprehensive overhaul. Using more strategic go-to-market processes, they ushered their specialty pharmacy innovations into the modern era. Today, they continue to lead the way with their pioneering reputation and forge a path towards a more transformative future.
Armed with firsthand insights and feedback from numerous patients, this physician had a uniquely clear vision of the market's requirements. The problem was that he was up against a saturated landscape commanded by well-established household brands with deep pockets and enduring customer loyalty. The challenge lay in carving a distinctive niche. Leveraging a dynamic and robust commercialization strategy along with a bold brand identity, his product managed to not only capture the spotlight but also secure coveted shelf space within prominent big-box retailers.
It’s easy to coast along when you’re making a profit in an industry that’s full of growth and opportunity. But this independent pharmacy buying group wanted to take it to the next level. With a robust strategic marketing plan and by leveraging modern tools, tactics, and best practices, they were able to drive rapid growth and transform into an online destination for independent pharmacy owners.
With a lean team and limited resources, this company harnessed a late-entrant advantage, crafting an ingenious brand strategy that utilized a SaaS model and AI to creatively exploit the gaps left by dominant market players. The result? They were not only able to compete against industry giants, they went on to absorb their top competitor in just two years, reshaping the market landscape.
In an industry barreling toward commoditization, this specialty pharmacy recognized the urgency of setting itself apart. Through a blend of enhanced, strategic branding and impactful messaging, they were able to secure their market position in the hearts and minds of patients and stakeholders, making them a desirable target for acquisition.
This specialty pharmacy built a strong name for itself in the HCV field - but struggled to stay visible in a saturated market. Leadership knew marketing resources were stretched thin, and they had no real strategic plan in place, but the market was experiencing massive growth. Capitalizing on that growth meant they needed a plan - a marketing plan. Two years later, with a strategic marketing plan and enhanced foundational assets in place, their net worth soared from $50 million to $500 million, making them an irresistible acquisition for the fifth-largest pharmacy in the United States.
This digital health startup set out to develop an early adoption strategy and a clear path to market. While developing the strategies that would help them avoid pitfalls, circumvent failure, and recognize opportunities, COVID hit. Armed with their newly acquired early adoption vision, they were able to confidently perform a powerful pandemic pivot to success.
